COST- MINIMIZATION ANALYSIS OF THE DIRECT COSTS OF SEVELAMER CARBONATE AND LANTHANUM CARBONATE IN THE TREATMENT OF CKD-ND PATIENTS
Value Health
.
2014 Nov;17(7):A470.
doi: 10.1016/j.jval.2014.08.1332.
Epub 2014 Oct 26.
Authors
M K Petrov
1
,
M Dimitrova
2
,
G I Petrova
3
Affiliations
1
Sanofi Bulgaria, Sofia, Bulgaria.
2
Medical University of Sofia, Faculty of Pharmacy, Sofia, Bulgaria.
3
Medical University, Faculty of Pharmacy, Sofia, Bulgaria.
PMID:
27201344
DOI:
10.1016/j.jval.2014.08.1332
No abstract available